Browse comprehensive healthcare market research reports across all industry segments.
The In Vitro Diagnostics (IVD) market is advancing through rising disease prevalence, innovative technologies, AI-driven analytics, and point-of-care testing, while facing strong competition, regulatory complexity, high costs, data integration, and quality challenges.
Idiopathic pulmonary fibrosis treatment is advancing beyond traditional antifibrotics, with novel targets and combination therapies emerging. Despite clinical challenges, growing patient needs and continued investment are shaping the future of IPF care.
The global GLP-1 analogues market includes injectable and oral GLP-1 receptor agonists used to treat type 2 diabetes and obesity by improving blood glucose control, promoting weight loss, and reducing cardiovascular risk. Market growth is driven by the rising prevalence of diabetes and obesity, expanding clinical indications, increasing patient and physician awareness, and continuous innovation in GLP-1 therapies.
The next-generation sequencing (NGS) market includes advanced sequencing platforms, instruments, reagents, software, bioinformatics tools, and sequencing services used for rapid DNA and RNA analysis. NGS is widely applied in clinical diagnostics, oncology, infectious disease testing, reproductive genetics, rare disease research, precision medicine, drug discovery, agriculture, and genomics research. Growth is driven by increasing adoption of genomic technologies and personalized medicine.